Core Viewpoint - The announcement details the release of share pledges by major shareholder Cai Nanguai, indicating a potential shift in the company's ownership structure and investor sentiment [1]. Group 1: Share Pledge Release - Cai Nanguai, the largest shareholder of Sailong Pharmaceutical Group Co., Ltd., has notified the company about the release of part of his pledged shares, specifically 16,000,000 shares, which accounts for 9.09% of his holdings and 23.70% of the company's total shares [1]. - Cai Nanguai holds a total of 67,512,703 shares, making him the largest shareholder, although he is not the controlling shareholder or actual controller of the company [1]. Group 2: Pledged Shares Overview - As of the announcement date, the total pledged shares by Cai Nanguai and his concerted actors are detailed, with no shares currently frozen or auctioned, and no non-operating fund occupation or illegal guarantees affecting the company's interests [2]. - The company will continue to monitor the changes in shareholding and fulfill its information disclosure obligations in accordance with relevant regulations [2].
*ST赛隆: 关于公司股东部分股份解除质押的公告